Fieldview Capital Management LLC Invests $4.79 Million in Corteva, Inc. $CTVA

Fieldview Capital Management LLC acquired a new stake in shares of Corteva, Inc. (NYSE:CTVA) during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor acquired 70,821 shares of the company’s stock, valued at approximately $4,790,000. Corteva comprises approximately 0.8% of Fieldview Capital Management LLC’s investment portfolio, making the stock its 16th biggest position.

Other hedge funds also recently bought and sold shares of the company. Norges Bank bought a new position in Corteva during the second quarter valued at approximately $434,220,000. Pacer Advisors Inc. lifted its holdings in shares of Corteva by 4,007.1% in the 3rd quarter. Pacer Advisors Inc. now owns 2,442,177 shares of the company’s stock worth $165,164,000 after acquiring an additional 2,382,715 shares during the last quarter. Marshall Wace LLP lifted its holdings in shares of Corteva by 1,365.9% in the 2nd quarter. Marshall Wace LLP now owns 1,809,764 shares of the company’s stock worth $134,882,000 after acquiring an additional 1,686,309 shares during the last quarter. National Pension Service boosted its stake in shares of Corteva by 148.4% in the 2nd quarter. National Pension Service now owns 2,454,601 shares of the company’s stock valued at $182,941,000 after purchasing an additional 1,466,268 shares in the last quarter. Finally, Qube Research & Technologies Ltd boosted its stake in shares of Corteva by 566.0% in the 2nd quarter. Qube Research & Technologies Ltd now owns 1,247,120 shares of the company’s stock valued at $92,948,000 after purchasing an additional 1,059,872 shares in the last quarter. Institutional investors own 81.54% of the company’s stock.

Insiders Place Their Bets

In other news, insider Brian Titus sold 8,311 shares of Corteva stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $76.55, for a total value of $636,207.05. Following the sale, the insider directly owned 8,090 shares in the company, valued at approximately $619,289.50. This trade represents a 50.67% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.15% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently commented on CTVA shares. Wolfe Research lifted their target price on shares of Corteva from $81.00 to $86.00 and gave the stock an “outperform” rating in a research report on Thursday, February 5th. Citigroup upped their price target on shares of Corteva from $74.00 to $80.00 and gave the company a “neutral” rating in a research report on Thursday, February 5th. CICC Research raised their price objective on Corteva from $70.00 to $80.00 and gave the company an “outperform” rating in a research note on Wednesday, February 11th. Wall Street Zen lowered Corteva from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. Finally, Mizuho increased their target price on Corteva from $80.00 to $82.00 and gave the company an “outperform” rating in a report on Tuesday, February 17th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $82.80.

Corteva Price Performance

Shares of Corteva stock opened at $76.95 on Monday. The firm has a market cap of $51.75 billion, a PE ratio of 48.70, a price-to-earnings-growth ratio of 2.63 and a beta of 0.72. Corteva, Inc. has a 12-month low of $53.40 and a 12-month high of $80.90. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. The company’s fifty day simple moving average is $73.00 and its two-hundred day simple moving average is $69.00.

Corteva (NYSE:CTVA) last issued its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, meeting the consensus estimate of $0.22. The firm had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $4.23 billion. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The company’s quarterly revenue was down 1.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.32 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, equities analysts expect that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 16th. Shareholders of record on Monday, March 2nd will be given a dividend of $0.18 per share. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s dividend payout ratio is presently 45.57%.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.